top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Advances in the Treatment of Renal Cell Carcinoma
Advances in the Treatment of Renal Cell Carcinoma
Autore Reynolds Paul
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (221 p.)
Soggetto topico Medicine
Soggetto non controllato artesunate (ART)
autophagy
biomarker
biomarkers
ccRCC
chloroquine
clear cell renal cell carcinoma
cysteine cathepsin inhibitors
cysteine cathepsins
evolution
evolutionary trajectory
ferroptosis
genomic signature
growth inhibition
hydroxychloroquine
immune checkpoint inhibitors
immune-based combination therapies
immunotherapy
individualization
kidney cancer
lysosome
metastatic
metastatic renal cell carcinoma
mRCC
network meta-analysis
PD-L1
predictive
RCC
reactive oxygen species (ROS)
renal cancer
renal cell cancer
renal cell carcinoma
renal cell carcinoma (RCC)
ROC-325
second line therapy
soluble factors
sunitib resistance
TKIs
Traditional Chinese Medicine (TCM)
transcriptomic analysis
treatment
tyrosine kinase inhibitors
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557615503321
Reynolds Paul  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
New Therapies of Liver Diseases
New Therapies of Liver Diseases
Autore Toniutto Pierluigi
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (236 p.)
Soggetto topico Public health and preventive medicine
Soggetto non controllato acute-on-chronic liver failure
acute-on-chronic liver failure (ACLF)
alcoholic hepatitis
alpha-fetoprotein
ammonia
anti-mineralocorticoids
antivirals
ascites
autoantibodies
bleeding
cholangiocarcinoma
cirrhosis
cirrhotic ascites
clinical trials
colorectal cancer metastases
decompensated cirrhosis
decompensation
effective hypovolemia
Farnesoid X Receptor (FXR) agonist
functional cure
furosemide
HBV
HDV
hepatocellular carcinoma
human albumin
humoral response
immunosuppressant
immunotherapy
infection
liver cancer
liver injury
liver transplantation
liver transplantation (LT)
loop diuretics
Milan criteria
n/a
non-selective beta-blockers
Pan-Peroxisome Proliferator-Activated Receptor (PPAR) agonists
pharmacology
portal hypertension
portal-systemic shunt
primary biliary cholangitis
primary biliary cholangitis (PBC)
primary sclerosing cholangitis (PSC)
real-world
rifaximin
SARS-CoV-2
second line therapy
solid organ transplantation
statins
survival
survival rate
systemic treatment
targeted therapy
TIPS
tolvaptan
treatment response
unresectable hepatocellular carcinoma
ursodeoxycholic acid
ursodeoxycholic acid (UDCA)
vaccination
vaptans
varices
vigilance
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910566457403321
Toniutto Pierluigi  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui